Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PMVP

PMV Pharmaceuticals Inc

May 13 • 04:00PM ET

1.29

-0.13 -9.15 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: NVCT BCAB BDTX CCCC GLUE

| Held by: VTI VXF IWC BTEC AVTM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.48	Insider Own	8.32%	Shs Outstand	53.33M	Perf Week	-11.03%
Market Cap	68.80M	Forward P/E	-	EPS next Y	-1.12	Insider Trans	0.00%	Shs Float	48.89M	Perf Month	-12.24%
Enterprise Value	-24.46M	PEG	-	EPS next Q	-0.40	Inst Own	57.59%	Short Float	5.39%	Perf Quarter	15.18%
Income	-78.34M	P/S	-	EPS this Y	1.13%	Inst Trans	-7.26%	Short Ratio	3.96	Perf Half Y	-0.77%
Sales	0.00M	P/B	0.78	EPS next Y	23.69%	ROA	-58.65%	Short Interest	2.63M	Perf YTD	3.20%
Book/sh	1.65	P/C	0.74	EPS next 5Y	17.70%	ROE	-63.16%	52W High	1.88 -31.38%	Perf Year	51.37%
Cash/sh	1.75	P/FCF	-	EPS past 3/5Y	2.74% -13.98%	ROIC	-89.06%	52W Low	0.81 59.26%	Perf 3Y	-77.37%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.26% 4.56%	Perf 5Y	-95.56%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-26.14%	Oper. Margin	-	ATR (14)	0.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.14	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	39.42	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	11.14	EPS Q/Q	-0.77%	SMA20	-8.41%	Beta	1.42	Target Price	4.33
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-9.32%	Rel Volume	1.48	Prev Close	1.42
Employees	54	LT Debt/Eq	0.00	Earnings	May 12 BMO	SMA200	-3.99%	Avg Volume	664.48K	Price	1.29
IPO	Sep 25, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.07% -	Trades		Volume	985,036	Change	-9.15%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)